Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crum, R. M.
Right arrow Articles by Ford, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crum, R. M.
Right arrow Articles by Ford, D. E.

Psychosomatic Medicine, Vol 56, Issue 2 109-117, Copyright © 1994 by American Psychosomatic Society


ORIGINAL ARTICLES

Depressive symptoms among general medical patients: prevalence and one-year outcome

RM Crum, L Cooper-Patrick and DE Ford
Department of Epidemiology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland.

Using prospective data from the National Institute of Mental Health (NIMH) Epidemiologic Catchment Area surveys, we examined the relationship of depressive symptoms among patients seen by general medical practitioners, with the subsequent development of major depressive disorder. The goals of the analysis were to determine 1) the 1-year psychiatric status of these individuals, and 2) to evaluate factors associated with the risk of major depressive disorder (MDD) or dysthymia. Between 1980 and 1984, collaborators of the NIMH Epidemiologic Catchment Area program recruited 18,571 adult participants after probability sampling of census tracts and households in five metropolitan areas. To assess the occurrence of psychiatric conditions over time, staff administered the Diagnostic Interview Schedule soon after sampling and again at follow-up 1 year later. For this analysis, the study sample was limited to respondents who reported seeing a general medical physician in the previous 6 months and who were free of current depressive disorder at the baseline interview. Overall, 41% of the general medical patients reported experiencing at least one depressive symptom in the past 6 months. Between 3 and 5% of the individuals with depressive symptoms developed MDD or dysthymia at the follow-up interview. Although individuals with depressed mood had a slightly higher estimated relative risk compared with individuals with vegetative, or nonvegetative (cognitive) depressive symptoms, no single classification of symptoms was appreciably more likely to signal MDD or dysthymia 1 year later. However, the risk of depression increased with the number of depressive symptoms reported.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
FocusHome page
D. V. Iosifescu, A. A. Nierenberg, J. E. Alpert, M. Smith, S. Bitran, C. Dording, and M. Fava
The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder
Focus, January 1, 2005; 3(1): 69 - 75.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
D. V. Iosifescu, A. A. Nierenberg, J. E. Alpert, G. I. Papakostas, R. H. Perlis, S. Sonawalla, and M. Fava
Comorbid Medical Illness and Relapse of Major Depressive Disorder in the Continuation Phase of Treatment
Psychosomatics, October 1, 2004; 45(5): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
R. H. Perlis, D. V. Iosifescu, J. Alpert, A. A. Nierenberg, J. F. Rosenbaum, and M. Fava
Effect of Medical Comorbidity on Response to Fluoxetine Augmentation or Dose Increase in Outpatients With Treatment-Resistant Depression
Psychosomatics, June 1, 2004; 45(3): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. H. Golden, J. E. Williams, D. E. Ford, H.-C. Yeh, C. Paton Sanford, F. J. Nieto, and F. L. Brancati
Depressive Symptoms and the Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities study
Diabetes Care, February 1, 2004; 27(2): 429 - 435.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
D. V. Iosifescu, A. A. Nierenberg, J. E. Alpert, M. Smith, S. Bitran, C. Dording, and M. Fava
The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder
Am J Psychiatry, December 1, 2003; 160(12): 2122 - 2127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. S. Kwon, Y.-M. Kim, C.-G. Chang, B.-J. Park, L. Kim, D. J. Yoon, W.-S. Han, H.-J. Lee, and I. K. Lyoo
Three-Year Follow-Up of Women With the Sole Diagnosis of Depressive Personality Disorder: Subsequent Development of Dysthymia and Major Depression
Am J Psychiatry, December 1, 2000; 157(12): 1966 - 1972.
[Abstract] [Full Text]


Home page
PsychosomaticsHome page
C. G. Lyketsos, F. Taragano, G. J. Treisman, and J. Paz
Major Depression and Its Response to Sertraline in Primary Care vs. Psychiatric Office Practice Patients: Results of an Open-Label Trial in Argentina
Psychosomatics, February 1, 1999; 40(1): 70 - 75.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Psychosomatic Society